Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1953 1
1957 1
1958 1
1959 1
1960 3
1961 2
1962 3
1963 3
1964 6
1965 5
1966 2
1968 1
1969 1
1970 1
1972 1
1973 2
1974 2
1975 2
1976 1
1977 1
1978 3
1980 2
1982 2
1984 4
1985 3
1988 1
1989 1
1990 5
1993 2
1994 3
1995 2
1996 1
1999 3
2000 1
2001 2
2002 1
2003 1
2004 2
2005 2
2006 3
2007 9
2008 4
2009 2
2010 3
2011 1
2012 1
2013 6
2014 1
2015 3
2017 1
2018 3
2019 2
2020 1
2021 3
2022 7
2023 3
2024 1
2025 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

134 results

Results by year

Filters applied: . Clear all
Page 1
Magnetic field therapy: a review.
Markov MS. Markov MS. Electromagn Biol Med. 2007;26(1):1-23. doi: 10.1080/15368370600925342. Electromagn Biol Med. 2007. PMID: 17454079 Review.
Ustekinumab as Induction and Maintenance Therapy for Ulcerative Colitis.
Sands BE, Sandborn WJ, Panaccione R, O'Brien CD, Zhang H, Johanns J, Adedokun OJ, Li K, Peyrin-Biroulet L, Van Assche G, Danese S, Targan S, Abreu MT, Hisamatsu T, Szapary P, Marano C; UNIFI Study Group. Sands BE, et al. N Engl J Med. 2019 Sep 26;381(13):1201-1214. doi: 10.1056/NEJMoa1900750. N Engl J Med. 2019. PMID: 31553833 Free article. Clinical Trial.
Vedolizumab versus Adalimumab for Moderate-to-Severe Ulcerative Colitis.
Sands BE, Peyrin-Biroulet L, Loftus EV Jr, Danese S, Colombel JF, Törüner M, Jonaitis L, Abhyankar B, Chen J, Rogers R, Lirio RA, Bornstein JD, Schreiber S; VARSITY Study Group. Sands BE, et al. N Engl J Med. 2019 Sep 26;381(13):1215-1226. doi: 10.1056/NEJMoa1905725. N Engl J Med. 2019. PMID: 31553834 Clinical Trial.
XXIst century magnetotherapy.
Markov M. Markov M. Electromagn Biol Med. 2015 Sep;34(3):190-6. doi: 10.3109/15368378.2015.1077338. Electromagn Biol Med. 2015. PMID: 26444192 Review.
Rosuvastatin and cardiovascular events in patients undergoing hemodialysis.
Fellström BC, Jardine AG, Schmieder RE, Holdaas H, Bannister K, Beutler J, Chae DW, Chevaile A, Cobbe SM, Grönhagen-Riska C, De Lima JJ, Lins R, Mayer G, McMahon AW, Parving HH, Remuzzi G, Samuelsson O, Sonkodi S, Sci D, Süleymanlar G, Tsakiris D, Tesar V, Todorov V, Wiecek A, Wüthrich RP, Gottlow M, Johnsson E, Zannad F; AURORA Study Group. Fellström BC, et al. N Engl J Med. 2009 Apr 2;360(14):1395-407. doi: 10.1056/NEJMoa0810177. Epub 2009 Mar 30. N Engl J Med. 2009. PMID: 19332456 Free article. Clinical Trial.
Bioeffects of weak electromagnetic fields.
Pilla AA, Markov MS. Pilla AA, et al. Among authors: markov ms. Rev Environ Health. 1994 Jul-Dec;10(3-4):155-69. doi: 10.1515/reveh.1994.10.3-4.155. Rev Environ Health. 1994. PMID: 7724875 Review.
Protect children from EMF.
Markov M, Grigoriev Y. Markov M, et al. Electromagn Biol Med. 2015 Sep;34(3):251-6. doi: 10.3109/15368378.2015.1077339. Electromagn Biol Med. 2015. PMID: 26444201
134 results